Risk factors for tia

Transient ischemic attack

Biller J, Ruland S, Schneck MJ. Ischemic cerebrovascular disease. In Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL, eds. Bradley’s Neurology in Clinical Practice. Philadelphia, PA: Elsevier; 2016:chap 65.

January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused updated of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J AM Coll Cardiol. 2019 Jan 21. pii: S0735-1097(19)30209-8. PMID: 30703431 www.ncbi.nlm.nih.gov/pubmed/30703431.

Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236. PMID: 24788967 www.ncbi.nlm.nih.gov/pubmed/24788967.

Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832. PMID: 25355838 www.ncbi.nlm.nih.gov/pubmed/25355838.

Riegel B, Moser DK, Buck HG, et al; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Quality of Care and Outcomes Research. Self-care for the prevention and management of cardiovascular disease and stroke: a scientific statement for healthcare professionals from the American Heart Association. J Am Heart Assoc. 2017;6(9). pii: e006997. PMID: 28860232 www.ncbi.nlm.nih.gov/pubmed/28860232.

What is a transient ischemic attack (TIA)?

The tests include:

  • Blood tests: Tests will check blood pressure, cholesterol levels and clotting ability.
  • Electrocardiogram (ECG): This records the electrical activity and rhythms of the heart.
  • Echocardiogram: This is an ultrasound scan that checks the pumping action of the person’s heart.
  • Chest X-ray: This helps the doctor rule out other conditions.
  • CT scan: The scan creates a 3-D image that can show aneurysms, bleeding, or abnormal vessels within the brain.
  • MRI scan: An MRI gives a more detailed view of the brain than a CT scan, and helps identify any brain damage.
  • Ultrasound: A wand waved over the carotid arteries in the neck can provide a picture that indicates any narrowing or clotting.


Share on PinterestSmoking is a significant risk factor in strokes.

The measures below can help reduce the risk of having a TIA, stroke, or a recurrent TIA:

  • Giving up smoking reduces the risk of stroke, TIA, and many other conditions.
  • Following a well-balanced diet, with plenty of fruit and vegetables, whole grains, fish, poultry, and very lean meat. Avoiding all junk foods and foods with bad fats, such as saturated and trans fats, may also be helpful.
  • Reducing salt (sodium) intake. Individuals prone to high blood pressure should avoid salty foods and not add salt to cooking.
  • Exercising moderately for at least 30 minutes five times a week. However, people should check with their doctor before they begin an exercise program.
  • Reducing the amount of alcohol consumed. Either don’t drink alcohol at all, or stay within the daily recommended limits.
  • Losing weight and bringing body weight down to normal levels will decrease risk.
  • Taking illegal drugs, such as cocaine, significantly raises the risk of stroke and TIA.
  • Controlling diabetes through proper medication and sticking to treatment plans greatly reduces the risk of stroke and TIA.
  • Getting at least 7 hours good quality, continuous sleep every day.

What Is Transient Ischemic Attack?

A transient ischemic attack (TIA)—also referred to as a mini-stroke—occurs when blood flow to part of the brain is interrupted by a temporary blockage in an artery supplying the brain. The pathological mechanism of a TIA is identical to that of certain kinds of stroke, except that normal circulation is restored within 24 hours and no permanent brain damage occurs.

Most TIAs are short-lived, resolving within a few minutes to an hour. Symptoms appear suddenly and vary considerably depending on the part of the brain affected. Although TIA symptoms disappear completely without treatment, they often recur. Prompt medical attention is important: TIAs are a warning sign of an impending stroke. Approximately 15 percent of all ischemic strokes are preceded by a TIA, and up to 17 percent of TIAs are followed by a full-blown ischemic stroke in the next three months.

Who Gets Transient Ischemic Attack?

About 240,000 Americans suffer a TIA each year.


  • Sudden weakness, tingling, or numbness, usually affecting only one side of the body.
  • Double vision or temporary blindness in

one eye.

  • Speech difficulty.
  • Dizziness and loss of balance or coordination.
  • Lightheadedness, confusion, or amnesia.
  • Headache or eye pain.

Causes/Risk Factors

  • The majority of TIAs are associated with atherosclerosis, a buildup of plaques in the walls of the arteries. A TIA may develop when a plaque becomes substantial enough to reduce blood supply locally in an artery supplying the brain. More commonly, however, a TIA occurs when a small fragment of a plaque that has broken off from a blood vessel, or a blood clot (embolus), usually from the heart, travels to an artery supplying the brain and lodges in a site already narrowed by atherosclerosis.
  • Major risk factors for TIAs include high blood pressure, heart disease, diabetes, smoking, aging, and a previous history of TIA.


  • Patient history and physical examination are needed to rule out other disorders such as epileptic seizures and migraines.
  • Blood tests are taken to rule out disorders like hypoglycemia.
  • Imaging studies may be done, such as MRI (magnetic resonance imaging) of the brain or ultrasound scans of the carotid arteries.
  • Cerebral arteriography (injection of a contrast material into the blood vessels supplying the brain to highlight them during an x-ray, CAT scan, or MRI) may be performed in some cases.


  • Drugs that inhibit blood clot formation may be prescribed. Anti-platelet medications, which reduce clots by interfering with the aggregation (clumping together) of blood cells called platelets, are often prescribed to people who have had a TIA. Anti-platelet agents include aspirin, clopidogrel (Plavix), and aspirin plus dipyridamole (Aggrenox). More powerful anticoagulants such as warfarin and heparin may be warranted in some cases.
  • Measures to control hypertension and blood cholesterol levels (including drug therapy) are undertaken if needed.
  • Patients who have experienced one or more TIAs, who are healthy enough to have surgery, and who show evidence of substantial atherosclerotic narrowing in the carotid arteries (the two main blood vessels in the neck supplying the brain) may be good candidates for carotid endarterectomy—a surgical procedure to clear away plaque deposits in the arteries. This technique is not appropriate for all patients, but in those who do qualify, it has been shown to reduce the risk of having a stroke in the future.


  • Seek treatment for any predisposing condition, such as hypertension, high cholesterol, diabetes, or heart disease.
  • Don’t smoke.
  • Lose weight if you are overweight.

When To Call Your Doctor

  • If you experience the symptoms of a TIA, contact your doctor immediately. Do not ignore symptoms just because they go away by themselves.

Reviewed by Joseph V. Campellone, M.D., Division of Neurology, Cooper University Hospital, Camden, NJ. Review provided by VeriMed Healthcare Network.

Transient Ischemic Attack: Part II. Risk Factor Modification and Treatment

2. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline . Stroke. 2006;37(6):1583–1633.

4. Bushnell CD, Zimmer LO, Pan W, et al.; Adherence Evaluation After Ischemic Stroke–Longitudinal Investigators. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67(12):1456–1463.

5. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke. 2003;34(10):2475–2481.

6. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(4):1024.

7. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34(11):2741–2748.

8. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1–2):1–13.

9. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Stroke. 2008;39(4):1358–1363.

10. Amarenco P, Bogousslavsky J, Callahan A III, et al.; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–559.

11. Amarenco P, Goldstein LB, Szarek M, et al.; SPARCL Investigators. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007;38(12):3198–3204.

14. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906–915.

15. Rothwell PM, Howard SC, Dolan E, et al.; ASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–480.

20. Keenan PS. Smoking and weight change after new health diagnoses in older adults. Arch Intern Med. 2009;169(3):237–242.

22. Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183(12):1359–1366.

26. Spence JD. Nutrition and stroke prevention. Stroke. 2006;37(9):2430–2435.

27. Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women . Circulation. 2009;119(8):1093–1100.

29. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes. Stroke. 2007;38(6):1739–1743.

30. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association . Diabetes Care. 2009;32(1):187–192.

32. Kooy A, de Jager J, Lehert P, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med. 2009;169(6):616–625.

36. Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004;62(11):2015–2020.

38. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35(12):2879–2883.

39. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292.

40. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352(13):1293–1304.

41. Steinhubl SR, Bhatt DL, Brennan DM, et al.; CHARISMA Investigators. Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009;150(6):379–386.

42. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A; ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial . Lancet. 2006;367(9523):1665–1673.

44. Diener HC, Bogousslavsky J, Brass LM, et al.; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331–337.

45. Amarenco P, Goldstein LB, Sillesen H, et al.; SPARCL Investigators. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010;41(3):426–430.

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *